Brad C. Webb
Private Equity Investor bei Claremont Creek Ventures
Profil
Brad Webb brings three decades of entrepreneurial and investing experience in the biomedical and biotechnology industries to CCV.
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
Brad led CCV's investments in Genalyte and co-led CCV's investment in AssureX and Numedii.
He represents CCV on the Boards of all three companies.
Prior to CCV, Brad worked in the medical device industry, mainly focused on devices and procedures used in eye surgery.
Brad was a founding member of several start-up ventures in the ophthalmic products industry, mainly responsible for research, clinical and regulatory affairs.
Brad was the founder of Vision Biology which developed new viscoelastic products used in eye surgery (acquired by Alcon Laboratories, now a division of Novartis).
Previously, Brad was a Research & Development scientist at 3M Company in the ophthalmology products division, where he led product design teams and supervised clinical trials and regulatory processes.
He has recently participated in investments in several biotech and medical technology companies.
Brad holds a PhD from the University of California Santa Barbara in Biochemistry and Molecular Biology, and a Masters Degree and Bachelor's degree in Chemistry.
Brad is a member of Tech Coast Angels, is active with UC Santa Barbara technology programs and advises several startups.
Aktive Positionen von Brad C. Webb
| Unternehmen | Position | Beginn |
|---|---|---|
Claremont Creek Ventures
 Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | Private Equity Investor | 01.01.2005 |
Ehemalige bekannte Positionen von Brad C. Webb
| Unternehmen | Position | Ende |
|---|---|---|
Freedom Meditech, Inc.
 Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.12.2016 |
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Direktor/Vorstandsmitglied | 30.09.2016 |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | 30.06.2015 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - |
| 3M COMPANY | Corporate Officer/Principal | - |
Ausbildung von Brad C. Webb
| University of California, Santa Barbara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 3M COMPANY | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Claremont Creek Ventures
Claremont Creek Ventures Investment ManagersFinance Claremont Creek Ventures (Claremont Creek) is a venture capital firm founded in 2005 by Nat Goldhaber, Randy Hawks and John Steuart. The firm is headquartered in Oakland, California. | Finance |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
Genalyte, Inc.
 Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | Health Technology |
Freedom Meditech, Inc.
Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |
